OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications
Jinxia Chen, Zhiyuan Xu, Can Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
Jinxia Chen, Zhiyuan Xu, Can Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
Showing 26-50 of 34 citing articles:
Claudin-18.2 immunohistochemical evaluation in gastric and gastroesophageal junction adenocarcinomas to direct targeted therapy: a practical approach
Matteo Fassan, Takeshi Kuwata, Kristina A. Matkowskyj, et al.
Modern Pathology (2024) Vol. 37, Iss. 11, pp. 100589-100589
Closed Access | Times Cited: 1
Matteo Fassan, Takeshi Kuwata, Kristina A. Matkowskyj, et al.
Modern Pathology (2024) Vol. 37, Iss. 11, pp. 100589-100589
Closed Access | Times Cited: 1
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma
Shufei Lai, Shaohong Luo, Qingwen Huang, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 5-6, pp. 249-257
Closed Access
Shufei Lai, Shaohong Luo, Qingwen Huang, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 5-6, pp. 249-257
Closed Access
SHP2 mediates the ROS/JNK/NFAT4 signaling pathway in gastric cancer cells prompting lncRNA SNHG18 to drive gastric cancer growth and metastasis via CAR-T cells
Lin An, Yue Huo, Na Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34008-e34008
Open Access
Lin An, Yue Huo, Na Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34008-e34008
Open Access
Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
K. Maeda, Takeshi Uehara, Waki Hosoda, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155537-155537
Closed Access
K. Maeda, Takeshi Uehara, Waki Hosoda, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155537-155537
Closed Access
CAR-T therapy for gastrointestinal cancers: current status, challenges, and future directions
Weidong Li, Yueming Huang, Xinhao Zhou, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access
Weidong Li, Yueming Huang, Xinhao Zhou, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access
Claudine 18.2 : nouvelle cible thérapeutique dans les cancers digestifs
Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin du Cancer (2024) Vol. 111, Iss. 12, pp. 1133-1141
Open Access
Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin du Cancer (2024) Vol. 111, Iss. 12, pp. 1133-1141
Open Access
Relationship between [18F]FDG PET/CT findings and claudin 18.2 expression in metastatic gastric cancer
Hongyan Yin, Rongkui Luo, Jing Lv, et al.
European Radiology (2024)
Closed Access
Hongyan Yin, Rongkui Luo, Jing Lv, et al.
European Radiology (2024)
Closed Access
Emerging targets in gastric and pancreatic cancer: Focus on Claudin 18.2
Alireza Tojjari, Yassine Alami Idrissi, Anwaar Saeed
Cancer Letters (2024) Vol. 611, pp. 217362-217362
Closed Access
Alireza Tojjari, Yassine Alami Idrissi, Anwaar Saeed
Cancer Letters (2024) Vol. 611, pp. 217362-217362
Closed Access
A Comprehensive Study of the Oncogenic Function of Claudin-18 in Various Human Cancers
Xianbing Hou, Dandan Chen, Yao Wang
Research Square (Research Square) (2023)
Open Access
Xianbing Hou, Dandan Chen, Yao Wang
Research Square (Research Square) (2023)
Open Access
Current status of immunotherapy in gastric cancer
Ke Ji, Jiafu Ji
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access
Ke Ji, Jiafu Ji
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access
